Trial Profile
Low-dose Versus Standard-dose Capecitabine Adjuvant Chemotherapy for Chinese Elderly Patients With Stage II/III Colorectal Cancer: A Randomized, Phase 3 Non-inferiority Study
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms LcACEC
- 18 Dec 2014 New trial record